Research Participants
Our current studies looking for volunteers to join!
Evaluating clinical predictors for return to work following acute concussion
As part of the Ready Assessment of Diagnostics and Prognostics (RAPID) for Concussion Study, this project follows patients throughout their recovery to track their return-to-work process. We will provide patients with concussion education resources and up-to-date return-to-work guidelines and aim to identify prognostic indicators of protracted return to work following an acute concussion.
We are recruiting individuals presenting to the Foothills Medical Centre Emergency Department between 18 and 65 years old within one week of sustaining a concussion. Patients will provide blood for the assessment of biomarkers for concussion diagnosis and prognosis. Follow-up assessments include repeat blood draws and questionnaire measures to evaluate recovery and return to work status.
RAPID Concussion Study
The Ready Assessment of Prognostic Indicators and Diagnostics (RAPID) Concussion Study is focused on the analysis of blood biomarkers for the diagnosis and prognosis of concussion.
We are recruiting individuals presenting to the Foothills Medical Centre Emergency Department between 18 and 65 years old within 2 weeks of sustaining a concussion. Patients will provide blood for assessment of biomarkers for concussion diagnosis and prognosis. Follow-up assessments include repeat blood draws and questionnaire measures to evaluate recovery.
Imaging for TBI Study
We are inviting individuals for an online interview and focus group to share their personal experience of concussion or TBI, or looking after others with TBI or concussion. We will provide the opportunity for people to share their thoughts on what information is important to them when considering future types of brain scans and investigations. The discussions may take up to 1.5 hours of their time. For this study you are at least 18 years old and have access to a computer, tablet, or smartphone with stable internet connection.
You may be eligible to take part if :
1. You or a loved one sustained a concussion or TBI, and the diagnosis was at least 6 weeks ago. OR
2. You are a professional working in the healthcare, insurance or legal field regularly working with survivors of TBI or concussion.
Pathophysiology of Post-traumatic Headache Study
This study will use neuroimaging, blood biomarkers and questionnaires to understand chronic headache following concussion. We are recruiting two groups 1) healthy adults with no history of headache disorder or concussion and 2) individuals experiencing chronic post-traumatic headache (headache following concussion that has persisted for at least 3-months post-concussion). Only one assessment visit will be required where the neuroimaging scan, blood draw and questionnaires will take place. We will also ask participants to complete 4-weeks of brief electronic headache diaries (<5mins a day).
Treatment of Post Concussion Syndrome with psilocybin trial
Our study is investigating the potential of psilocybin-assisted therapy, a promising approach that combines a carefully administered dose of psilocybin with tailored psychotherapy, to improve PPCS symptoms. Participants will be randomly assigned to receive either an active control or treatment dose of psilocybin, followed by 5 sessions of acceptance and commitment therapy.
We are recruiting participants aged 18-65 with diagnosed concussions and persistent symptoms (3 months to 5 years) for a psilocybin-assisted therapy protocol. Your participation will include: a starting in-person assessment, personalized preparation with your therapist, a supervised psilocybin session, weekly therapy to support your progress, a 3-month in-person follow-up, and a final online questionnaire at 6 months.
Treatment of PTSD with Psilocybin trial
Our study is investigating the potential of psilocybin-assisted therapy, a promising approach that combines a carefully administered dose of psilocybin with tailored psychotherapy, to improve PTSD symptoms in survivors of intimate partner violence. Participants will be randomly assigned to receive either an active control or treatment dose of psilocybin, followed by 5 sessions of acceptance and commitment therapy.
We are recruiting participants aged 19-65 with symptoms of PTSD and last incident of IPV > 6-months for a psilocybin-assisted therapy protocol. Your participation will include: a starting in-person assessment, personalized preparation with your therapist, a supervised psilocybin session, weekly therapy to support your progress, a 3-month online follow-up, and a final 6 month in-person follow-up.
